Publication | Closed Access

Curcumin reverses doxorubicin resistance in colon cancer cells at the metabolic level

OncologyDoxorubicin ResistanceMetabolic LevelChemoprevention StrategyMedicineColon Cancer CellsPharmacologyColorectal CancerPathologyAnti-cancer AgentCancer BiologyCancer ResearchDrug Resistance